Longitudinal characterisation of cachexia in patients undergoing surgical resection for cancer

Abstract

Purpose of review The complexity of the cancer cachexia phenotype has undoubtedly hindered researchers’ understanding of this devastating syndrome. The presence and magnitude of host–tumour interactions are rarely considered during clinical decision-making within the current staging paradigm. Furthermore, treatment options for those patients who are identified as suffering from cancer cachexia remain extremely limited. Recent findings Previous attempts to characterise cachexia have largely focussed on individual surrogate disease markers, often studied across a limited timeframe. While the adverse prognostic value of clinical and biochemical features is evident, the relationships between these are less clear. Investigation of patients with earlier-stage disease could allow researchers to identify markers of cachexia that precede the refractory stage of the wasting process. Appreciation of the cachectic phenotype within ‘curative’ populations may aid our understanding of the syndrome’s genesis and provide potential routes for prevention, rather than treatment. Summary Holistic, longitudinal characterisation of cancer cachexia, across all at-risk and affected populations, is of vital importance for future research in the field. This paper presents the protocol for an observational study aiming to create a robust and holistic characterisation of surgical patients with, or at risk of, cancer cachexia.